ACTICOR BIOTECH: Availability of the 2021 Universal Registra

Regulatory News: ACTICOR BIOTECH (ISIN: FR0014005OJ5 ALACT) (Paris:ALACT), a clinical-stage biotechnology company developing an innovative drug for the treatment of cardiovascular emergencies, announces

Related Keywords

Mediolanum , Lombardia , Italy , Paris , France General , France , Faubourg Saint Jacques , Bourgogne , French , Newton Biocapital , Venture Investment , French National Institute Of Health , Regulatory News , Universal Registration Document , Combined General Meeting , Des March , Entreprises Paris Cochin , Acticor Biotech , Bulletin Des Annonces , General Meeting , Vaccine Pass , French Commercial , French Commercial Code , French National Institute , Medical Research , Mirae Asset Capital , Primer Capital , Euronext Growth Paris , Acticor , Biotech , Availability , 021 , Niversal , Registration , Document , Preparatory , Documents , Combined , Eneral , Meeting , 022 ,